Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,314.5
26.3 (0.80%)

 

  • STI Straits Times Index
    3,314.5
    26.3 (0.80%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,675.4
    8.9 (0.53%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,550.4
    348.3 (1.23%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,987.1
    69.3 (2.38%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    21,462.9
    129.0 (0.60%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,335.7
    -3.6 (-0.06%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,131.3
    6.5 (0.31%)
    Index delayed 20 minutes
  • XAO XAO
    6,767.9
    39.4 (0.59%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 902.7M
  • Value: 1,251.9M
  • Rise: 194
  • Fall: 127
  • Unch: 520

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
SingTel3.450+0.070
ISR Capital^0.003-
Rex Intl0.071-
Genting Sing0.925+0.020
G Invacom^0.087-0.004
Golden Agri-Res0.285+0.005
Asian Pay Tv Tr0.172-0.005
CromwellReit EUR0.505-0.020
NetLink NBN Tr0.875-0.005
Jiutian Chemical0.015-

World Indices

World Indices
Name Last Change
Nasdaq 7,987.3 +33.4
HSI 28,550.4 +348.3
HSCEI 10,922.4 +157.7
Jakarta 6,335.7 -3.6
Nikkei 225 21,462.9 +129.0
SSE Comp 2,987.1 +69.3
Shanghai A 3,128.8 +72.7
Shanghai B 292.9 +3.2
ShenZhen A 1,627.9 +31.2
ShenZhen B 947.5 +14.0
Taiwan W 10,785.0 +9.7
PSE Comp 0.0
KOSPI 2,131.3 +6.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

QT Vascular QT VASCULAR LTD.
Quotes 10 Minutes Delayed. Updated at 20 Jun 2019 17:02
Last (SGD): 0.003 Change: - High: 0.003 Remarks: -
Change (%): - Low: 0.003
Open 0.003 Yesterday's Close 0.003
Buy Price 0.003 Sell Price 0.004
Buy Volume ('000) 13,212.7 Sell Volume ('000) 17,526.6
Cumulative Volume ('000) 6,979.3 Cumulative Value 20,938
 
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01801 Trailing EPS (SGD) e 0.00148 NAV (SGD) b 0.0087
PE a 0.167 Trailing PE f 2.030 Price / NAV b 0.3448
Dividend (SGD) d - Cash In Hand (SGD) g 0.0049 Issued & Paid-up Shares c 2,235,272,000
Dividend Yield (%) d - Price / Cash In Hand g 0.612 Treasury Shares h -
Beta - 75 Daysi 0.677 R-Squared - 75 Days(%)i 0.17 Market Cap (M) 6.706
Beta - 500 Daysi 0.779 R-Squared - 500 Days (%)i 0.57 Enterprise Value (M) -0.306
Piotroski F Score 4 Exchange Code 5I0 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 99.8428 6-Month VWAP 0.005 Free Float (%) 86.6
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Mining - Biotechnology
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Jun 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference QT Vascular SGX 6.706 0.167 2.030 0.3448 -
Industry Biotechnology SGX 1,983.583 7.325 7.675 0.6875 4.756
Medical & Biotechnology SGX 1,034.705 23.684 23.839 1.4362 1.819
Index FTSE ST Catalist Index SGX 79.285 117.554 - 0.9056 2.219
Local Peer Lonza SGX 5,937.453 7.663 7.663 0.6889 4.766
Local Peer Suntar Eco-City^ SGX 6.590 - - 0.3743 -
Global Peer AMGEN INC NASDAQ 111,478.003 13.281 13.805 10.2916 2.982
Global Peer GILEAD SCIENCES INC NASDAQ 86,796.686 15.911 14.731 3.9541 3.368
Global Peer AMGEN-T HKEx 609,936.000 9.271 9.631 7.1731 4.272
Global Peer CELGENE CORP NASDAQ 68,995.586 17.053 14.541 8.4502 -
Global Peer CSL ASX 99,445.885 44.569 40.821 14.4288 1.039
Global Peer ILLUMINA INC NASDAQ 51,735.180 62.633 60.793 12.9825 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 46,549.992 22.205 21.602 9.8554 -
Global Peer BIOGEN INC NASDAQ 45,349.634 10.235 9.718 3.2791 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 34,078.888 13.942 14.038 3.6083 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 27,753.813 357.655 66.652 2.8593 -
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), EXACT SCIENCES CORP (NASDAQ), SINO BIOPHARM (HKEx), SEATTLE GENETICS INC (NASDAQ), WUXI BIO (HKEx), ARRAY BIOPHARMA INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BEIGENE-B (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BLUEBIRD BIO INC (NASDAQ), EXELIXIS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MODERNA INC (NASDAQ), GENSCRIPT BIO (HKEx), BLUEPRINT MEDICINES CORP (NASDAQ), TILRAY INC (NASDAQ), 3SBIO (HKEx), SPARK THERAPEUTICS INC (NASDAQ), REPLIGEN CORP (NASDAQ), FIBROGEN INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALKERMES PLC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), INSMED INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), GENOMIC HEALTH INC (NASDAQ), XENCOR INC (NASDAQ), REGENXBIO INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), INTREXON CORP (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), ALECTOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), EPIZYME INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ASCLETIS-B (HKEx), DECIPHERA PHARMACEUTICALS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), HAOHAI BIOTEC (HKEx), ROCKET PHARMACEUTICALS INC (NASDAQ), FRONTAGE (HKEx), MYOVANT SCIENCES LTD (NYSE), HOMOLOGY MEDICINES INC (NASDAQ), RETROPHIN INC (NASDAQ), MACROGENICS INC (NASDAQ), OMEROS CORP (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), VIVA BIOTECH (HKEx), ARVINAS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), POLYNOVO LIMITED (ASX), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), NEXT SCIENCE LTD (ASX), MAGENTA THERAPEUTICS INC (NASDAQ), ESSEX BIO-TECH (HKEx), PUMA BIOTECHNOLOGY INC (NASDAQ), DERMIRA INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), CKLIFE SCIENCES (HKEx), MERIDIAN BIOSCIENCE INC COM (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), CYMABAY THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), KODIAK SCIENCES INC (NASDAQ), SYNTHORX INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), MEDICINOVA INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), LEE'S PHARM (HKEx), PROTHENA CORP PLC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AGENUS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MERUS B V (NASDAQ), AVROBIO INC (NASDAQ), NEXTCURE INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), IMMUNOGEN INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), GERON CORP (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CHIASMA INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SYNLOGIC INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), KADMON HLDGS INC (NYSE), AXCELLA HEALTH INC (NASDAQ), KAMADA (NASDAQ), MANNKIND CORPORATION (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), RECRO PHARMA INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), COMPUGEN (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), ENZO BIOCHEM INC (NYSE), X4 PHARMACEUTICALS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), SERES THERAPEUTICS (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), TELIX PHARMACEUTIC (ASX), CHIMERIX INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PFENEX INC (NYSE American), XOMA CORP (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ARDELYX INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), BBI LIFE SCI (HKEx), ADURO BIOTECH INC (NASDAQ), TOCAGEN INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), IMV INC (NASDAQ), VERASTEM INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), AVEO PHARMACEUTICALS INC (NASDAQ), SESEN BIO INC (NASDAQ), NANTKWEST INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), INMUNE BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), TREVENA INC (NASDAQ), UNI-BIO GROUP (HKEx), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), SAVARA INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), INFINITY PHARMACEUTICALS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), INFLARX N V (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), PORT (SET), NEUREN PHARMACEUTICALS LTD (ASX), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), VERMILLION INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), IBIO INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), MERRIMACK PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ARAVIVE INC (NASDAQ), ORGENESIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), CEL-SCI CORP (NYSE American), IMMUTEP LTD (ASX), ORGANOVO HLDGS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), VACCINEX INC (NASDAQ), REGENT PACIFIC (HKEx), CT ENTERPRISE (HKEx), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), IVERIC BIO INC (NASDAQ), CURIS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), ZAFGEN INC (NASDAQ), ORTHOCELL LIMITED (ASX), SUNESIS PHARMACEUTICALS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), PHYLOGICA LIMITED (ASX), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), IMUGENE LIMITED (ASX), EVOGENE LTD (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), AZURRX BIOPHARMA INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), VISTAGEN THERAPEUTICS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), NOVABAY PHARMACEUTICALS INC (NYSE American), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), BIOTRON (ASX), BIONANO GENOMICS INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), EXTRAWELL PHAR (HKEx), RHINOMED LIMITED (ASX), BIOSINO BIO-TEC (HKEx), ORAGENICS INC (NYSE American), ISORAY INC (NYSE American), ONCOSIL MEDICAL LIMITED (ASX), ZELDA THERAPEUTICS LTD (ASX), BIONOMICS LTD (ASX), REXAHN PHARMACEUTICALS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), CELLECTAR BIOSCIENCES INC (NASDAQ), BIOCEPT INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), VICAL INC (NASDAQ), HISTOGENICS CORP (NASDAQ), PATRYS LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), COLLPLANT HOLDINGS LTD SPON ADR EACH REP 50 ORD(POST REV SPLT) (NASDAQ), PRECIPIO INC (NASDAQ), ADVAXIS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), PULMATRIX INCORPORATED (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), NOVELION THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), TROVAGENE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), ADALTA LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), SOLIGENIX INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), IMMURON LIMITED (ASX), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), VAXART INC (NASDAQ), OHR PHARMACEUTICAL INC (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), HAO WEN HLDGS (HKEx), HOLISTA COLLTECH LIMITED (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), BENITEC BIOPHARMA LTD (ASX), REGENEUS LTD (ASX), CELLMID LIMITED (ASX), MEMPHASYS LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), CYCLACEL PHARMA IN (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), MGRC (Bursa), NEURALSTEM INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BIOXYNE LIMITED (ASX), OPGEN INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), MEGASUN (Bursa), ACTINOGEN MEDICAL LTD (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), CYTORI THERAPEUTICS INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), CCP TECHNOLOGIES LTD (ASX), NOVITA HEALTHCARE LTD (ASX), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), TRILLIUM THERAPEUTICS INC (NASDAQ), NANOLLOSE LTD (ASX), BPH ENERGY LIMITED (ASX), MEDIBIO LIMITED (ASX), ALCHEMIA LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX), SINOVAC BIOTECH (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days ---
20 Days ---
Medium Term Return 3 Months --0.003
-50.00 %
6 Months --0.005
-62.50 %
1 Year --0.011
-78.57 %
Long Term Return 2 Years --0.026
-89.66 %
3 Years --0.087
-96.67 %
5 Years --0.512
-99.42 %
Annualised Return Annualised --
-64.27 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.003 - 0.014 Change From 1 Year Low - % Change From 1 Year Low (%) -
Change From 1 Year High -0.011 % Change From 1 Year High (%) -78.57
2 Years Range 0.003 - 0.029 Change From 2 Years Low - % Change From 2 Years Low (%) -
Change From 2 Years High -0.026 % Change From 2 Years High (%) -89.66
5 Years Range 0.003 - 0.525 Change From 5 Years Low - % Change From 5 Years Low (%) -
Change From 5 Years High -0.522 % Change From 5 Years High (%) -99.43
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group is engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The Group collaborates with industry specialists and physicians who are key opinion leaders to develop and offer physicians and patients new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.

IPO Performance

Listing Date 29 Apr 2014 Full Subscription Rate (x) -
No of Placement Shares (M) 196.43 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) 0.280 First Day Close (SGD) 0.340 First Week Close (SGD) 0.345
Current vs IPO Price (%) -98.93 First Day Gain (%) +21.43 First Week Gain (%) +23.21

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2018 Dec 2018 Part 1(1.05 MB)
Part 2(0.10 MB)
Annual Report 2017 Dec 2017 Part 1(0.91 MB)
Part 2(0.08 MB)
Annual Report 2016 Dec 2016 Part 1(1.60 MB)
Part 2(0.47 MB)
Annual Report 2015 Dec 2015 Part 1(0.82 MB)
Part 2(0.20 MB)
Annual Report 2014 Dec 2014 Part 1(2.05 MB)
Part 2(0.42 MB)
Annual Report 2013 Dec 2013 Part 1(1.04 MB)
IPO Prospectus
IPO Prospectus 2014 Apr 2014 Part 1(3.55 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
20 Jun 2019 0.003 0.003 0.003 0.003 6,979,300 0.0030
19 Jun 2019 0.003 0.003 0.003 0.003 1,520,000 0.0030
18 Jun 2019 0.003 0.003 0.003 0.003 1,000,000 0.0030
17 Jun 2019 0.003 0.003 0.003 0.003 55,000 0.0030
14 Jun 2019 0.003 0.003 0.003 0.003 - -
13 Jun 2019 0.004 0.004 0.003 0.003 56,000 0.0038
12 Jun 2019 0.004 0.004 0.004 0.004 - -
11 Jun 2019 0.004 0.004 0.004 0.004 200,000 0.0040
10 Jun 2019 0.003 0.004 0.003 0.004 600,000 0.0035
07 Jun 2019 0.003 0.003 0.003 0.003 370,000 0.0030
06 Jun 2019 0.003 0.003 0.003 0.003 110,000 0.0030
04 Jun 2019 0.003 0.003 0.003 0.003 - -
03 Jun 2019 0.003 0.003 0.003 0.003 11,645,900 0.0030
31 May 2019 0.003 0.003 0.003 0.003 197,000 0.0030
30 May 2019 0.003 0.003 0.003 0.003 - -
29 May 2019 0.003 0.003 0.003 0.003 - -
28 May 2019 0.003 0.003 0.003 0.003 1,389,700 0.0030
27 May 2019 0.003 0.003 0.003 0.003 6,442,200 0.0030
24 May 2019 0.003 0.003 0.003 0.003 610,000 0.0030
23 May 2019 0.004 0.004 0.003 0.003 850,000 0.0034
22 May 2019 0.003 0.003 0.003 0.003 900,000 0.0030
21 May 2019 0.004 0.004 0.004 0.004 350,000 0.0040
Summary
Current 2 Weeks
(07 Jun 2019 to 20 Jun 2019)		 0.003 0.004 0.003 0.003 10,780,300 -
Previous 2 Weeks
(23 May 2019 to 06 Jun 2019)		 0.004 0.004 0.003 0.003 21,244,800 -
4 Weeks from
(23 Apr 2019 to 22 May 2019)		 0.004 0.004 0.003 0.003 24,105,000 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.